Rick Winningham is Chief Executive Officer of Theravance Biopharma, Inc. (TBPH). The company reported total compensation of $1,472,019 for fiscal year 2025.
| Salary | $1,047,431 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $0 |
| Non-equity incentive plan | $419,182 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $5,406 |
| Total | $1,472,019 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Theravance Biopharma, Inc. filed April 28, 2026, accession 0001104659-26-050454.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer | $1,047,431 | $0 | $0 | $0 | $419,182 | $0 | $5,406 | $1,472,019 |
| FY2024 | Chief Executive Officer | $1,047,431 | $9,802 | $2,443,500 | $0 | $490,198 | $0 | $5,000 | $3,995,931 |
Totals as disclosed in each year's own compensation disclosure for Theravance Biopharma, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Rick Winningham this page | Chief Executive Officer | $1,472,019 |
| Aine Miller | Senior Vice President, Development and Head of Ireland Office | $1,448,573 |
| Rhonda Farnum | Chief Business Officer and Senior Vice President, Commercial & Medical Affairs | $1,384,192 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Theravance Biopharma, Inc. compensation brief.
Rick Winningham's compensation sits inside Theravance Biopharma, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.